Defense Advanced Research Projects AgencyWork With UsOpportunities

Opportunities

Established in 1958 as part of the U.S. Department of Defense, DARPA pursues opportunities for transformational change rather than incremental advances. It does so collaboratively as part of a robust innovation ecosystem that includes academic, corporate, and governmental partners. To fulfill its mission, the Agency relies on diverse performers from throughout this ecosystem to apply multi-disciplinary approaches to both advance knowledge through basic research and create innovative technologies that address current and predicted practical problems through applied research. The list of selected opportunities displayed below is provided for convenience. For a complete listing of DARPA opportunities please visit the FedBizOpps website. More

In addition to program-specific opportunities, each DARPA technical office maintains an “office-wide” Broad Agency Announcement (BAA) that covers a range of technical areas of interest to each particular office. The office-wide BAAs are refreshed on an annual basis and offer a mechanism for researchers to reach DARPA with ideas that they feel could be valuable to national security.

 

Response date: 4/23/2020
Biological Technologies
BTO
This announcement seeks revolutionary research ideas for topics not being addressed by ongoing BTO programs or other published solicitations.
Response date: 11/19/2019
Focused Pharma
BTO
Military service members and veterans face serious occupational trauma; one element in particular relates to the significantly increased risk of acute and chronic neuropsychiatric conditions. Neuropsychiatric conditions in the military are particularly impactful because options for treating them are limited. No therapy currently exists that can deliver rapid relief of neuropsychiatric symptoms and is reasonable for use in a broad spectrum of conditions. Neuropsychiatric conditions are complex, and presentation is highly subject to significant inter-individual variability. Focused Pharma aims to develop new drugs that target specific neurotransmitter receptor signaling modes to deliver near immediate relief that is generalizable across indications and individuals.
Response date: 12/19/2019
Pecan
BTO
DARPA seeks expertise in synthetic biology and biochemistry of microbial communities.
Response date: 1/9/2020
Nucleic Acids On-Demand World-Wide (NOW)
BTO
The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.
Response date: 1/22/2020
Bridging the Gap Plus (BGPlus)
BTO
The Bridging the Gap Plus (BG+) program will develop new approaches to treating spinal cord injury by developing systems that address acute injury stabilization regenerative therapy as well as chronic functional restoration.